Orgenesis Inc.

Orgenesis Inc.
Stock Exchange Other OTC
EPS
$1.42
Market Cap
$68.17 M
Shares Outstanding
16.11 M
Public Float
11.85 M

Profile

Address
20271 Goldenrod Lane
Germantown Maryland 20876
United States
Employees -
Website http://www.orgenesis.com
Updated 07/08/2019
Orgenesis, Inc. engages in the cell therapy development and manufacturing for advanced medicinal products. It focuses on developing novel and proprietary cell therapy trans-differentiation technologies for the treatment of diabetes. It operates through the Contract Development and Manufacturing Organization (CDMO), and Cellular Therapy Business (CT) segments.

Financials

View All

Vered Caplan
Chairman, President & Chief Executive Officer
Ashish Nanda
Independent Director